Previous 10 | Next 10 |
home / stock / invvy / invvy news
RICHMOND, Va. , Nov. 11, 2019 /PRNewswire/ -- Indivior PLC (LON: INDV) announces the launch of a new direct-to-consumer (DTC) advertising campaign, Keep Moving Towards Recovery , which aims to heighten awareness of treatment with SUBLOCADE® (buprenorphine extended-release) injection...
The FDA has granted Braeburn Pharmaceuticals' ( BBRX ) Citizen Petition seeking a revocation of Orphan Drug status for Indivior PLC's ( OTCPK:INVVY ) Sublocade (buprenorphine extended-release) injection, approved in the U.S. on November 30, 2017 for the treatment of moderate-to-severe op...
Indivior PLC (INVVY) Q3 2019 Earnings Conference Call October 31, 2019 08:00 AM ET Company Participants Shaun Thaxter - Chief Executive Officer and Executive Director Mark Crossley - Chief Financial and Operations Officer and Executive Director Christian Heidbreder - Chief Scient...
The following slide deck was published by Indivior PLC in conjunction with their 2019 Q3 earnings Read more ...
SLOUGH, England and RICHMOND, Va. , Oct. 31, 2019 /PRNewswire/ -- Indivior PLC (LON: INDV) today announced that its Q3/YTD 2019 results press release and investor supplement are now available via the London Stock Exchange's Regulatory News Service (RNS) and on the "Inves...
RICHMOND, Va. , Sept. 26, 2019 /PRNewswire/ -- Indivior PLC (LON: INDV) announces that the National Institutes of Health (NIH) has granted Indivior's application entitled " Clinical Evaluation of C4X3256, a Non-Opioid, Highly-Selective Orexin-1 Receptor Antagonist for the Treat...
Indivior PLC (INVVY) Q2 2019 Earnings Conference Call July 31, 2019 6:30 AM ET Company Participants Shaun Thaxter - Chief Executive Officer Mark Crossley - Chief Financial & Operations Officer Javier Rodriguez - Chief Legal Officer Christian Heidbreder - Chief Scientific Of...
The following slide deck was published by Indivior PLC in conjunction with their 2019 Q2 earnings Read more ...
SLOUGH, England and RICHMOND, Va. , July 31, 2019 /PRNewswire/ -- Indivior PLC (LON: INDV) today announced that its first half 2019 results press release and investor supplement are now available via the London Stock Exchange's Regulatory News Service (RNS) and on the "Inve...
Today's top stories: S&P 3000; firing up the 'half pointers'; and French tax adds to trade tensions. If you are interested in listening to Wall Street Breakfast to start your day, look for us in the following places: iTunes (find all Seeking Alpha Podcasts here ) Stitcher...
News, Short Squeeze, Breakout and More Instantly...
Indivior to Host Analyst Teach-in Event in New York City; Reconfirms Full Year 2024 Guidance PR Newswire RICHMOND, Va. , May 23, 2024 /PRNewswire/ -- Indivior PLC (LSE: INDV; Nasdaq: INDV), a leading addiction treatment company, announced that in anticipation o...
Indivior Announces Q1 2024 Financial Results PR Newswire SLOUGH, United Kingdom and RICHMOND, Va. , April 25, 2024 /PRNewswire/ -- Indivior PLC (LSE/Nasdaq: INDV) today announced its financial results for the period ending March 31, 2024 . The earnings re...
Indivior Announces Publication Demonstrating that OPVEE® (nalmefene) Nasal Spray Rapidly Reverses Effects of Opioid-Induced Respiratory Depression in Head-to-Head Study Against Intranasal Naloxone PR Newswire This head-to-head pharmacodynamic study in healthy volunteers...